Incremental third-party costs associated with COPD exacerbations: a retrospective claims analysis

References

• Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (Updated 2009) 2009; http://www.goldcopd.com/download.asp?intId=554. Accessed 6 April, 2010
   Google Scholar
• Xu J, Kochanek KD, Murphy SL, Tejada-Vera B. Deaths: Final Data for 2007. National Vital Statistics Report 2010; http://www.cdc.gov/nchs/data/nvsr/nvsr58/nvsr58_19.pdf. Accessed 27 August, 2010
   Google Scholar
• Gudmundsson G, Gislason T, Lindberg E, et al. Mortality in COPD patients discharged from hospital: the role of treatment and co-morbidity. Respir Res 2006;7:109
   PubMed Web of Science ®Google Scholar
• American Lung Association. Trends in COPD (Chronic Bronchitis and Emphysema): Morbidity and Mortality. Report 2010; http://www.lungusa.org/finding-cures/our-research/trend-reports/copd-trend-report.pdf. Accessed 6 April, 2010
   Google Scholar
• National Heart Lung and Blood Institute. Morbidity and Mortality: 2009 Chart Book on Cardiovascular, Lung, and Blood Diseases 2009; http://www.nhlbi.nih.gov/resources/docs/2009_ChartBook.pdf. Accessed 6 April, 2010
   Google Scholar
• Effing TW, Kerstjens HA, Monninkhof EM, et al. Definitions of exacerbations: does it really matter in clinical trials on COPD? Chest 2009;136:918–23
   PubMed Web of Science ®Google Scholar
• Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest 2000;117(5 Suppl 2):398–401S
   PubMed Web of Science ®Google Scholar
• Simoens S, Decramer M, Laekeman G. Economic aspects of antimicrobial therapy of acute exacerbations of COPD. Respir Med 2007;101:15–26
   PubMed Web of Science ®Google Scholar
• Anzueto A, Sethi S, Martinez FJ. Exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2007;4:554–64
   PubMedGoogle Scholar
• Sullivan SD, Ramsey SD, Lee TA. The economic burden of COPD. Chest 2000;117(2 Suppl):5–9S
   PubMed Web of Science ®Google Scholar
• Hilleman DE, Dewan N, Malesker M, et al. Pharmacoeconomic evaluation of COPD. Chest 2000;118:1278–85
   PubMed Web of Science ®Google Scholar
• Andersson F, Borg S, Jansson SA, et al. The costs of exacerbations in chronic obstructive pulmonary disease (COPD). Respir Med 2002;96:700–8
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Murio C, Guerrero T, et al. Pharmacoeconomic evaluation of acute exacerbations of chronic bronchitis and COPD. Chest 2002;121:1449–55
   PubMed Web of Science ®Google Scholar
• Mittmann N, Kuramoto L, Seung SJ, et al. The cost of moderate and severe COPD exacerbations to the Canadian healthcare system. Respir Med 2008;102:413–21
   PubMed Web of Science ®Google Scholar
• Oostenbrink JB, Rutten-van Molken MP. Resource use and risk factors in high-cost exacerbations of COPD. Respir Med 2004;98:883–91
   PubMed Web of Science ®Google Scholar
• Connors AF, Jr., Dawson NV, Thomas C, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). Am J Respir Crit Care Med 1996;154(4 Pt 1):959–67
   PubMed Web of Science ®Google Scholar
• Mapel DW, Schum M, Lydick E, et al. A new method for examining the cost savings of reducing COPD exacerbations. Pharmacoeconomics. 2010;28:733–49
   PubMed Web of Science ®Google Scholar
• Dalal AA, Christensen L, Liu F, et al. Direct costs of chronic obstructive pulmonary disease among managed care patients. Int J Chron Obstruct Pulmon Dis 2010;5:341–9
   PubMedGoogle Scholar
• Dalal AA, Shah M, D'Souza AO, et al. Costs of inpatient and emergency department care for chronic obstructive pulmonary disease in an elderly Medicare population. J Med Econ 2010;13:591–8
   PubMedGoogle Scholar
• Dalal AA, Shah M, D'Souza AO, et al. Costs of COPD exacerbations in the emergency department and inpatient setting. Respir Med 2011;105:454–60
   PubMed Web of Science ®Google Scholar
• Antonelli Incalzi R, Fuso L, De Rosa M, et al. Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease. Eur Respir J 1997;10:2794–800
   PubMed Web of Science ®Google Scholar
• Adams SG, Melo J, Luther M, et al. Antibiotics are associated with lower relapse rates in outpatients with acute exacerbations of COPD. Chest 2000;117:1345–52
   PubMed Web of Science ®Google Scholar
• Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007;176:532–55
   PubMed Web of Science ®Google Scholar
• Delea TE, Stanford RH, Hagiwara M, et al. Association between adherence with fixed dose combination fluticasone propionate/salmeterol on asthma outcomes and costs. Curr Med Res Opin 2008;24:3435–42
   PubMed Web of Science ®Google Scholar
• Marton JP, Boulanger L, Friedman M, et al. Assessing the costs of chronic obstructive pulmonary disease: the state Medicaid perspective. Respir Med 2006;100:996–1005
   PubMed Web of Science ®Google Scholar
• Vijayasaratha K, Stockley RA. Reported and unreported exacerbations of COPD: analysis by diary cards. Chest 2008;133:34–41
   PubMed Web of Science ®Google Scholar
• O'Reilly JF, Williams AE, Holt K, et al. Defining COPD exacerbations: impact on estimation of incidence and burden in primary care. Prim Care Respir J 2006;15:346–53
   PubMedGoogle Scholar
• Suh DC, Lau H, La HO, et al. Association between incidence of acute exacerbation and medication therapy in patients with COPD. Curr Med Res Opin 2010;26:297–306
   PubMed Web of Science ®Google Scholar
• Calverley PM, Rabe KF, Goehring UM, et al. Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials. Lancet 2009;374:685–94
   PubMed Web of Science ®Google Scholar
• Hurst JR, Wedzicha JA. Management and prevention of chronic obstructive pulmonary disease exacerbations: a state of the art review. BMC Med 2009;7:40
   PubMed Web of Science ®Google Scholar